BetterLife Pharma Inc. (BETRF)
OTCMKTS · Delayed Price · Currency is USD
0.2300
-0.0700 (-23.33%)
Aug 10, 2026, 3:12 PM EST
BetterLife Pharma Market Cap
BetterLife Pharma has a market cap or net worth of $48.57 million as of August 10, 2026. Its market cap has increased by 307.98% in one year.
Market Cap
48.57M
Enterprise Value
51.67M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.23
ChartMarket Cap Chart
Since October 4, 2010, BetterLife Pharma's market cap has decreased from 98.33M to 48.57M, a decrease of -50.61%. That is a compound annual growth rate of -4.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 48.57M | 889.88% |
| Dec 31, 2025 | 4.91M | -47.43% |
| Dec 31, 2024 | 9.33M | 68.00% |
| Dec 29, 2023 | 5.55M | -49.28% |
| Dec 30, 2022 | 10.95M | -24.42% |
| Dec 31, 2021 | 14.49M | -81.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NDT Pharmaceuticals | 105.07M |
| HST Global | 99.00M |
| Biomind Labs | 62.06M |
| Cell Source | 55.94M |
| Arch Biopartners | 49.83M |
| Vicapsys Life Sciences | 46.94M |
| Sangamo Therapeutics | 46.40M |
| Nuo Therapeutics | 41.15M |